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Abstract 
Vitamin D3 (or cholecalciferol) is a fat-soluble vitamin widely used for the prevention and treatment of vitamin D 
deficiency disease. The aim of this study was to explore the impact of the Trivedi Effect®-Consciousness Energy Healing 
Treatment on the physical, chemical, and thermal properties of cholecalciferol using sophisticated analytical techniques. 
Cholecalciferol powder sample was divided into two parts, one part of cholecalciferol was considered as a control sample 
(no Biofield Treatment was provided), while second part received Biofield Energy Healing Treatment remotely by a 
popular Biofield Energy Healer, Dahryn Trivedi. The PXRD relative peak intensities and crystallite size of the treated 
cholecalciferol were significantly altered ranging from 17.35 to 60.14% and -30.02% to 99.79%, respectively compared 
to the control sample. The average crystallite sizes of the treated cholecalciferol were increased by 3.41% compared to 
the control sample. The particle size values in Dahryn’s treated cholecalciferol were significantly increased by 2.91% 
(d10), 3.73% (d50), 19.59% (d90), and 15.53% {D (4,3)}, respectively; thus, the specific surface area was significantly 
decreased by 20.41% compared to the control sample. Similarly, the melting point and latent heat of fusion of the treated 
cholecalciferol were lowered by 0.76% and 2.60%, respectively compared with the control sample. The total weight loss 
in the treated cholecalciferol was decreased compared to the control sample. The Tmax of the treated cholecalciferol was 
decreased by 3.32% compared to the control sample. The Consciousness Energy Healing Treatment might produce a new 
polymorphic form of cholecalciferol which would improve powder flow ability, shape, and appearance compared with the 
control sample. The Consciousness Energy Healing Treated cholecalciferol would be beneficial to design better 
nutraceutical and pharmaceutical formulations for the treatment of vitamin D deficiency, rickets, osteoporosis, cancer, 
diabetes mellitus, etc. 
 
Keywords: Cholecalciferol, Biofield Energy; The Trivedi Effect®; Consciousness Energy Healing Treatment; PXRD; PSA; 
DSC; TGA/DTG 
 
Abbreviations: PXRD: The powder X-ray diffraction; 
PSA: Particle Size Analysis; SSA: Specific Surface Area; 
TGA: Thermal Gravimetric Analysis; DTG: Differential 
thermogravimetric Analysis  
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Introduction 
Vitamin D3 or cholecalciferol is a fat-soluble secosteroid 
having cyclopentanoperhydro-phenanthrene ring system 
and possess antirachitic activity. It is produced from 7-
dehydrocholesterol by the photochemical reaction in the 
skin. It contains three double bonds which are usually 
responsible for the cis and trans conformation of 
cholecalciferol. It is air and light-sensitive compound 
[1,2]. It is a type of vitamin D which is found to be 
responsible for the enhancement of intestinal absorption 
of several vital minerals like calcium, zinc, magnesium, 
iron, and phosphate [3]. Vitamin D plays a vital role in 
several diseases, e.g., cancer, diabetes mellitus, rickets, 
osteoporosis, mental disorders, cardiovascular diseases, 
multiple sclerosis, infections [4-6]. Cholecalciferol is 
found in animal food sources, such as cod liver oil, milk, 
fatty fish like salmon, tuna, etc. Nowadays vitamin D 
deficiency is epidemic, mostly under-treated nutritional 
deficiency all over the world. Vitamin D can be used as a 
dietary supplement for the anticipation and treatment of 
vitamin D deficiency [5]. Cholecalciferol is a prohormone 
and is hydroxylated at position C-25 to convert 25-
hydroxycholecalciferol (also known as calcidiol), which is 
more circulating form. Consequently, the second form 
1,25-dihydroxycholecalciferol or calcitriol is biologically 
active [5-7]. Vitamin D toxicity i.e. hypercalcemia, 
polyuria, polydipsia, weakness, insomnia, mental 
retardation can be resultant with high dose 
supplementation [3]. The bioavailability and stability of 
vitamin D3 is a major concern [1,2]. Physicochemical 
properties of nutraceutical and pharmaceutical 
compounds are very important for better bioavailability 
and therapeutic efficacy.  
 
The Trivedi Effect®-Consciousness Energy Healing 
Treatment significantly altered the physicochemical and 
thermal properties of many pharmaceutical/nutraceutical 
compounds [8,9] and also improved the bioavailability of 
poorly bioavailable compounds (i.e., 25-hydroxyvitamin 
D3) in male Sprague-Dawley rats [10]. Biofield is referred 
as an energy matrix that that found surrounds the human 
body resulting from the constant movement of the 
electrically charged particles (i.e., ions, cells, etc.) inside 
the body and it continuous discharges the 
electromagnetic waves via bio-photons. The Biofield 
Energy Healers have the ability to harness the energy 
from the “Universe” and can transfer into any living or 
nonliving object(s) around the world. The process, where 
the object(s) receive the biofield energy and respond in a 
useful way is called as Biofield Energy Healing Treatment 
[11,12]. The Biofield Energy therapy has been recognized 
as a Complementary and Alternative Medicine health care 
approach by the National Center of Complementary and 
Integrative Health with other therapies, medicines and 
practices such as homeopathy, yoga, Qi Gong, 
chiropractic/osteopathic manipulation, meditation, 
acupressure, acupuncture, hypnotherapy, naturopathy, 
Ayurvedic medicine, Chinese herbs and medicines, Reiki, 
cranial sacral therapy, etc. [13]. The Bio field Energy 
Healing Treatment is also drawing importance in several 
fields include material science [14], organic compounds 
[15,16], microbiology [17], agriculture [18], 
biotechnology [19], genetics [20], medical [21], etc. 
Recent literature reported that the Consciousness Energy 
Healing Treatment has the astounding capability to alter 
physicochemical properties such as crystallite properties, 
particle properties, and thermal properties of various 
nutraceuticals through introducing a new polymorph [22-
26]. The physicochemical of a pharmaceutical solid 
compound play an important role in drug product 
performance [27,28]. The Consciousness Energy Healing 
Treatment changes the physicochemical properties 
through the possible intervention of neutrinos [29]. 
Therefore, this study was performed to investigate the 
effect of the Trivedi Effect®-Consciousness Energy 
Healing Treatment on the physical, chemical, and thermal 
properties of cholecalciferol using modern and 
sophisticated analytical techniques. 
 
Materials and Methods  
Chemicals and reagents 
The test sample cholecalciferol (>98%) was purchased 
from Sigma-Aldrich, India and other chemicals used 
during the experiments were also purchased in India. 
 
Consciousness energy healing treatment 
strategies 
The powder sample of cholecalciferol was divided into 
two parts. One part of cholecalciferol did not receive 
Biofield Energy Treatment and considered as a control 
sample. But, the control cholecalciferol was treated with a 
“sham” healer who did not have any awareness about the 
Biofield Energy Treatment. While the second part of 
cholecalciferol was received the Trivedi Effect®-
Consciousness Energy Healing Treatment remotely for 3 
minutes by the well-known Biofield Energy Healer, 
Dahryn Trivedi, USA known as the Biofield Energy 
Treated cholecalciferol. After the treatment, the Biofield 
Energy Treated and control test samples were kept in 
sealed conditions and characterized using various 
analytical techniques. 
 
Characterization 
The powder X-ray diffraction (PXRD) analysis of 
cholecalciferol powder sample was performed with the 
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help of PANalytical X’PERT3 powder X-ray diffractometer 
(UK) [22-24]. The average size of crystallites 
cholecalciferol powder was calculated from PXRD data 
using the Scherrer’s formula (1) 
 
G = kλ/βcosθ  (1) 
 
Where k is the equipment constant, λ is the radiation 
wavelength, G is the crystallite size in nm, β is the full-
width at half maximum, and θ is the Bragg angle [30].  
 
The particle size analysis (PSA) was performed using 
Malvern Mastersizer 3000 (UK) using the wet method 
[12-14]. Similarly, the differential scanning calorimetry 
(DSC) analysis of cholecalciferol was performed with the 
help of DSC Q2000 differential scanning calorimeter 
(USA). The thermogravimetric analysis (TGA) 
thermograms of cholecalciferol were obtained with the 
help of TGA Q500 themoanalyzer (USA) apparatus [22-
24]. The % change in the peak intensity, crystallite size, 
particle size, specific surface area, latent heat, melting 
point, weight loss and the maximum thermal degradation 
temperature of the treated cholecalciferol was calculated 
compared with the control cholecalciferol using the 
following equation2: 
 
  (2) 
Statistical analysis 
All the values were represented as Mean ± SD (standard 
deviation) of independent experiment. The statistical 
analysis was performed using Sigma Plot statistical 
software (v11.0). For two groups comparison student’s t-
test was used. Statistically significant values were set at 
the level of p≤0.05. 
 
Results and Discussion 
Powder X-ray diffraction (PXRD) analysis  
The PXRD diffractograms of the control and treated 
cholecalciferol samples of cholecalciferol (Figure 1) 
showed sharp and intense diffraction peaks indicating 
that both the samples were crystalline in nature. The 
values of the Bragg angle as shown in Figure 1 and other 
PXRD data of the control sample were matched with the 
reported values for cholecalciferol [1]. The PXRD 
diffractograms of the control and treated cholecalciferol 
samples showed the highest peak intensity (100%) at 
Bragg’s angle (2θ) equal to 18.2° (Table 1, entry 14). The 
relative intensities of the PXRD peaks in the Biofield 
Energy Treated cholecalciferol were significantly 
decreased from 17.35% to 60.14% compared to the 
control sample. The crystallite sizes of the treated 
cholecalciferol were significantly altered ranging from 
8.34% to 30.02% compared to the control sample. The 
average crystallite sizes of the Biofield Energy Treated 
cholecalciferol (44.55 nm) were increased by 3.41% 
compared to the control sample (43.08 nm). 
 
 
 
Figure 1: PXRD diffractograms of the control and treated cholecalciferol. 
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Entry No. Bragg angle (°2) 
Relative Intensity (%) Crystallite size (G, nm) 
Control Treated % change Control Treated % change 
1 5.0 96.91 67.31 -30.54 68.84 57.36 -16.67 
2 6.7 15.79 13.05 -17.35 28.72 49.26 71.51 
3 8.7 11.66 6.48 -44.43 49.32 43.15 -12.51 
4 9.0 8.27 4.97 -39.90 34.52 34.52 0.00 
5 13.1 19.09 10.51 -44.94 24.74 26.64 7.70 
6 13.7 25.01 17.16 -31.39 49.53 34.66 -30.02 
7 14.4 7.25 2.89 -60.14 38.54 49.57 28.61 
8 15.0 20.07 11.64 -42.00 57.81 57.81 0.00 
9 15.3 29.74 18.04 -39.34 43.41 43.41 0.00 
10 15.6 56.35 30.95 -45.08 57.84 43.43 -24.93 
11 15.9 56.88 31.52 -44.59 34.75 28.95 -16.67 
12 16.3 23.2 10.73 -53.75 24.83 34.76 40.04 
13 16.8 12.81 8.40 -34.43 31.62 28.98 -8.34 
14 18.2 100 100 0.00 49.80 43.57 -12.51 
15 18.8 8.81 5.03 -42.91 18.36 34.88 90.00 
16 19.5 7.26 3.94 -45.73 38.80 38.80 0.00 
17 21.9 30.88 17.33 -43.88 43.82 38.95 -11.12 
18 22.9 8.88 4.02 -54.73 25.08 39.02 55.61 
19 23.4 11.32 5.84 -48.41 70.24 58.53 -16.66 
20 23.8 18.13 10.57 -41.70 70.28 50.26 -28.49 
21 24.9 5.89 4.02 -31.75 44.07 88.05 99.79 
22 25.6 6.48 2.61 -59.72 35.30 29.41 -16.69 
23 27.0 6.24 3.72 -40.38 50.59 70.73 39.81 
24 Average crystallite size ± standard deviation (SD) 43.08±14.66 44.55±14.32 3.41 
Table 1: PXRD data for the control and treated cholecalciferol. 
 
The significant changes in the crystallite size and relative 
intensities indicated that the crystal morphology of the 
Biofield Energy Treated cholecalciferol was modified 
compared to the control sample. The recent literature 
reported that treatment has the significant capability to 
introduce a new polymorph by modifying crystal 
morphology of the pharmaceuticals and nutraceuticals 
through altering the relative intensities and crystallite 
size of characteristic diffraction face [22-24,31]. Thus, the 
Trivedi Effect®-Consciousness Energy Healing Treatment 
probably introduced a new crystalline polymorphic form 
through the energy transferred into cholecalciferol. 
Polymorphic forms of pharmaceuticals have the 
significant effects on the drug performance, such as 
bioavailability, therapeutic efficacy, and toxicity, because 
their thermodynamic and physicochemical properties like 
melting point, energy, stability, and especially solubility, 
are different (probably better) from the original form 
[32,33]. Thus, it can be anticipated that Dahryn’s Biofield 
Energy Treatment could be a very useful method for the 
production of novel crystal polymorph of cholecalciferol 
that would provide an improvement in its therapeutic 
performance. 
 
 Particle size distribution (PSD) analysis 
The particle size distribution of both the control and 
Biofield Energy Treated cholecalciferol was evaluated and 
presented in Table 2. The particle size distribution of the 
control cholecalciferol was observed at d10 = 108.53 µm, 
d50=340.93 µm, d90=718.24 µm, and D(4,3)=380.52 µm. 
Subsequently, the particle size distribution of the Biofield 
Energy Treated cholecalciferol was found at d10=111.69 
µm, d50=353.65 µm, d90=858.94 µm, and D 
(4,3)=439.63µm. The particle size values at d10, d50, d90, 
and D(4,3) in Dahryn’s Biofield Energy Treated 
cholecalciferol were significantly increased by 2.91%, 
3.73%, 19.59% and 15.53%, respectively compared to the 
control sample. The specific surface area (SSA) of Biofield 
Energy Treated cholecalciferol (31.47m2/Kg) was 
significantly reduced by 20.41% with respect to the 
control sample (39.54 m2/Kg). 
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Parameter d10 (µm) d50 (µm) d90 (µm) D(4,3) (µm) SSA (m2/Kg) 
Control 108.53 340.93 718.24 380.52 39.54 
Biofield Treated 111.69 353.65 858.94 439.63 31.47 
% change 2.91 3.73 19.59 15.53 -20.41 
Table 2: Particle size distribution of the control and treated cholecalciferol. 
 
d10, d50, and d90: particle diameter corresponding to 10%, 
50%, and 90% of the cumulative distribution, D(4,3): the 
average mass-volume diameter, and SSA: the specific 
surface area. 
 
The increased particle size and reduced surface area of 
the pharmaceutical compound are due to the enhanced 
the powder flowability, improved product shape, and 
appearance. It also affects the performance of 
formulations [34,35]. Thus, it is anticipated that the 
Trivedi Effect®-Consciousness Energy Healing Treated 
cholecalciferol might increase the powder flowability, 
shape and appearance of cholecalciferol. PXRD data also 
supported that the Biofield Energy Healing Treatment 
could change the size, shape, and appearance of 
cholecalciferol. 
 
Differential scanning calorimetric (DSC) analysis  
The DSC thermo grams of the control and Biofield Energy 
Treated cholecalciferol samples (Figure 2) exhibited two 
endothermic peaks at nearly 86 and 309°C and one 
exothermic peak at nearly 221°C. Literature mentioned 
that the sharp endothermic peak at 86.30°C in the DSC 
curve is the melting point of cholecalciferol and 
exothermic peak at 206°C may be due to the 
decomposition of cholecalciferol [1]. The DSC analysis 
revealed that the melting point of the Biofield Energy 
Treated cholecalciferol was reduced by 0.76% compared 
to the control sample as shown in Table 3. After that, the 
latent heat of fusion (∆H) of the Biofield Energy Treated 
cholecalciferol was decreased by 2.60% compared with 
the control sample.  
 
 
Figure 2: DSC thermograms of the control and Biofield Energy Treated cholecalciferol. 
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Sample 
Melting point/Decomposition Temperature 
(°C) 
∆H (J/g) 
1st Peak 2nd Peak 3rd Peak 1st Peak 2nd Peak 3rd Peak 
Control Sample 86.43 220.5 308.6 60.27 139.5 61.44 
Biofield Energy Treated 85.77 220.68 308.88 58.7 140.4 57.49 
%Change -0.76 0.08 0.09 -2.6 0.65 -6.43 
Table 3: DSC data for both control and treated cholecalciferol. 
ΔH: Latent heat of fusion/Enthalpy of decomposition. 
 
So, Biofield Energy Treated cholecalciferol required less 
energy in the form of ∆H to undergo the process of 
melting after Dahryn’s Biofield Energy Treatment. 
Consequently, the decomposition temperature and the 
latent heat of decomposition in the Biofield Energy 
Treated cholecalciferol were increased by 0.08%, and 
0.65%, respectively, compared to the control sample. The 
2nd broad endothermic peak at nearly 309°C may be the 
slow degradation of non-volatile intermediates produced 
during the thermal reaction. The melting point of this 
peak in the Biofield Energy Treated cholecalciferol was 
increased by 0.09% with a lowered and ∆H by 6.43% 
compared to the control sample. The results suggested 
that the thermal stability of the Biofield Energy Treated 
cholecalciferol was altered compared with the control 
sample.  
 
Thermal gravimetric analysis (TGA) / 
differential thermogravimetric analysis (DTG) 
Koshy and Beyer described that the TGA curve of 
cholecalciferol exhibited a sharp drop in weight at 128°C 
that might be due to the boiling and possible splattering 
of the sample [1]. The thermograms of the control and 
Biofield Energy Treated cholecalciferol showed two steps 
of thermal degradation (Figure 3). The percentage weight 
loss in Biofield Energy Treated cholecalciferol was 
significantly increased by 36.04% in the 1st step of 
degradation, while the % weight loss in the 2nd step 
degradation which showed the major weight loss was 
reduced by 0.53% compared with the control sample 
(Table 4). The total weight loss in the Biofield Energy 
Treated cholecalciferol was decreased by 0.12% 
compared with the control sample (Table 4).  
 
 
Figure 3: TGA thermograms of the control and Biofield Energy Treated cholecalciferol. 
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Sample 
TGA; Weight loss (%) 
Tmax (°C) 
1st step 2nd step Total 
Control Sample 1.11 98.62 99.73 310.84 
Biofield Energy Treated Sample 1.51 98.1 99.61 300.52 
% Change 36.04 -0.53 -0.12 -3.32 
Table 4: TGA/DTG data of the control and treated cholecalciferol. 
Tmax = the temperature at which maximum weight loss takes place in TG or peak temperature in DTA. 
 
 
 
Figure 4: DTG thermograms of the control and treated cholecalciferol. 
 
 
The DTG thermograms of the control and Biofield Energy 
Treated cholecalciferol (Figure 4) exhibited only one 
peak. The maximum thermal degradation temperature 
(Tmax) of the Biofield Energy Treated cholecalciferol 
(300.52°C) was decreased by 3.32% than the control 
sample (310.84 °C) as shown in Table 4. Overall, 
TGA/DTG revealed that the thermal stability of the 
treated cholecalciferol was considerably improved 
compared to the control sample. 
Conclusion 
The experimental results revealed that the Trivedi 
Effect®-Consciousness Energy Healing Treatment showed 
the significant effects on the crystal properties, particle 
size, surface area, and thermal stability of cholecalciferol. 
The PXRD relative peak intensities and crystallite size of 
the Biofield Energy Treated cholecalciferol were 
significantly altered ranging from 17.35 to 60.14% and -
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30.02% to 99.79%, respectively compared to the control 
sample. The average crystallite sizes of the treated 
cholecalciferol were increased by 3.41% compared to the 
control sample. The particle size values in Dahryn’s 
Biofield Energy Treated cholecalciferol were significantly 
increased by 2.91% (d10), 3.73% (d50), 19.59% (d90), and 
15.53% {D (4,3)}, respectively; thus, the specific surface 
area was significantly decreased by 20.41% compared to 
the control sample. The melting point and latent heat of 
fusion of the Biofield Energy Treated cholecalciferol were 
lowered by 0.76% and 2.60%, respectively compared 
with the control sample. The total weight loss in the 
Biofield Energy Treated cholecalciferol was decreased 
compared to the control sample. The Tmax of the Biofield 
Energy Treated cholecalciferol was decreased by 3.32% 
compared to the control sample. Overall, the thermal 
analysis indicated that the thermal stability of the treated 
cholecalciferol was reduced compared to the control 
sample. The Consciousness Energy Healing Treatment 
might have produced a new polymorphic form of 
cholecalciferol which would improve powder shape, 
flowability, and appearance compared with the control 
sample. The Biofield Energy Treated cholecalciferol would 
be very suitable to design better nutraceutical and 
pharmaceutical formulations against vitamin D deficiency, 
rickets, osteoporosis, cancer, diabetes mellitus, mental 
disorders, cardiovascular diseases, multiple sclerosis, and 
infections. 
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